Abdel-Wahab, Reham
Varadhachary, Gauri R.
Bhosale, Priya R.
Wang, Xuemei
Fogelman, David R.
Shroff, Rachna T.
Overman, Michael J.
Wolff, Robert A.
Javle, Milind
Funding for this research was provided by:
Merck Sharp & Dohme Corp.
University of Texas MD Anderson Cancer Center
Article History
Received: 14 February 2018
Accepted: 6 May 2018
First Online: 30 May 2018
Ethics approval and consent to participate
: This clinical trial (NCT00769483) was approved by the MD Anderson Institutional Review Board, and all study participants signed an informed consent.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.